New England Biolabs announced the release of the EnClose Cell-free dbDNA Synthesis Kit, developed in collaboration with Touchlight. This novel kit enable...
First-in-class oral therapy ATR-258 mimics the effects of exercise – driving fat loss, increasing muscle, and improving metabolism – with b...
Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease The US Food and Drug Administration (FDA...
While companies make decarbonization progress elsewhere, heat has been considered too challenging to progress. - ...
First study to demonstrate safe and selective administration of sustained and localized delivery of enzalutamide -Alessa Therapeutics (“...
— Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significant unmet ...
KOMO Biosciences, a developer of non-viral targeted insertion technologies, today announced that it has granted Syngenta, a world leader in agricultural ...
Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Royal Philips (NYSE: PHG, AEX: ...
dsm-firmenich, innovators in nutrition, health, and beauty, has announced the completion of a planned $10 million modernization program on its Schenectad...
CMIC Co., Ltd., a contract research organization (CRO) jointly owned by Blackstone and CMIC HOLDINGS Co. Ltd., announced a strategic partnership with...
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/NYSE: AZN) supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzuma...
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene...
Thermo Fisher Scientific Inc, the world leader in serving science, announced the opening of a new, 70,000 sq.ft. distribution center in Bracetown, County...
Lonza Group AG, a world-leading contract development and manufacturing organisation (CDMO), has announced its decision to establish a new Global Capability...
© 2026 Biopharma Boardroom. All Rights Reserved.
